D. E. Shaw & Co., Inc. - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 1 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2019$84,000
-44.7%
151,937
+83.5%
0.00%
Q4 2018$152,000
-8.4%
82,782
-6.3%
0.00%
Q3 2018$166,000
+268.9%
88,348
+165.4%
0.00%
Q2 2018$45,000
-80.5%
33,294
-69.7%
0.00%
Q1 2018$231,000
+40.0%
109,934
-17.8%
0.00%
Q4 2017$165,000
-70.8%
133,676
-73.1%
0.00%
-100.0%
Q3 2017$566,000
-91.1%
496,101
-91.1%
0.00%
-90.0%
Q2 2017$6,393,000
+1.9%
5,559,639
+13.4%
0.01%
-9.1%
Q1 2017$6,274,000
+255.5%
4,901,704
+250.0%
0.01%
+266.7%
Q4 2016$1,765,000
+127.7%
1,400,606
+276.1%
0.00%
+200.0%
Q3 2016$775,000
-86.2%
372,390
-51.7%
0.00%
-90.0%
Q2 2016$5,603,000
+592.6%
770,658
+391.5%
0.01%
+900.0%
Q1 2016$809,000
-63.3%
156,787
-40.4%
0.00%
-66.7%
Q4 2015$2,207,000
-73.1%
263,104
-77.3%
0.00%
-75.0%
Q3 2015$8,195,000
+3.7%
1,159,060
+63.3%
0.01%0.0%
Q2 2015$7,906,000
+70.0%
709,711
+26.2%
0.01%
+71.4%
Q1 2015$4,650,000
+21.9%
562,332
-12.6%
0.01%
+40.0%
Q4 2014$3,814,000
+125.1%
643,242
+58.3%
0.01%
+150.0%
Q3 2014$1,694,000
-33.1%
406,306
-25.9%
0.00%
-33.3%
Q2 2014$2,533,000
+38.6%
548,321
+35.9%
0.00%0.0%
Q1 2014$1,828,000
+267.8%
403,452
+315.9%
0.00%
+200.0%
Q4 2013$497,000
+146.0%
96,998
+51.9%
0.00%
Q3 2013$202,000
+35.6%
63,861
-12.1%
0.00%
Q2 2013$149,00072,6820.00%
Other shareholders
NOVAVAX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Caption Management, LLC 2,021,600$22,273,0001.23%
GREAT POINT PARTNERS LLC 4,500,000$2,479,0000.24%
SABBY MANAGEMENT, LLC 860,000$474,0000.23%
Sargent Investment Group, LLC 588,070$324,0000.16%
BB BIOTECH AG 8,330,000$4,589,0000.12%
GREAT POINT PARTNERS LLC 2,000,000$1,102,0000.11%
CENTAURUS FINANCIAL, INC. 7$12,000,0000.07%
Rock Springs Capital Management LP 3,250,000$1,790,0000.07%
Beirne Wealth Consulting Services, LLC 155,000$85,0000.07%
ACUTA CAPITAL PARTNERS, LLC 250,000$138,0000.07%
View complete list of NOVAVAX INC shareholders